Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests a mobile therapy app for anxiety and mood after stroke

Tests the MAYA app, a mobile cognitive behavioral therapy, in adults who had a stroke.

Plain-language title generated from the registry record
Registry title: Mobile Cognitive Behavioral Therapy for Stroke

Key facts

Where
New York, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 79 years old?

Source: NCT06689878, who can take part

Where in United States

  • Weill Cornell MedicineNew York, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Weill Medical College of Cornell University
Trial code
NCT06689878
Record updated
4 August 2026
Original description
This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.Read full original descriptionShow less

Mobile Cognitive Behavioral Therapy for Stroke

This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.

Inclusion: Age 40-79; Presence of clinically-significant anxiety and/or depression (as determined by an eligibility evaluation); Stroke that occurred 1 month or more prior to study initiation; Capacity to provide consent; No greater than mild cognitive difficulties based on an eligibility evaluation conducted as part of the study; If taking medication for depression and/or anxiety, must be on a stable dose for a minimum of 8 weeks prior to study initiation; Ability to use iPhone or iPad independently; Home internet access; Willingness to participate in the full study duration.

Exclusion: History of a bipolar or psychotic disorder; Current alcohol or substance use disorder; Severe depression and/or anxiety based on the initial evaluation and clinical judgment of the study doctor, which warrants a higher level of care and/or immediate referral to psychiatric services; Aphasia of moderate or greater severity (as determined during an eligibility evaluation); Non-fluency in English; Active suicidal ideation; Current engagement in psychotherapy is not grounds for exclusion unless the individual's psychotherapy is primarily focused on CBT; Any other clinical or medical reason in the study doctor's initial screening evaluation that suggests the study is not appropriate for the participant.

ClinicalTrials.gov NCT06689878